High Resolution Retina Imaging
Overview
To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera
Study Type
- Study Type: Observational [Patient Registry]
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: January 30, 2023
Clinical Trial Outcome Measures
Primary Measures
- Evolution of retina diseases
- Time Frame: From date of inclusion until the date of last documented progression , assessed up to 5 years
- Increase the clinical experience of using the rtx1 camera in various conditions with retinal impact
Participating in This Clinical Trial
Inclusion Criteria
- Persons over 12 years of age, of both sexes, presenting with retinal pathologies. – Beneficiaries of the health insurance Exclusion Criteria:
- Any abnormality preventing good quality OA imaging on both eyes – Major under guardianship or curatorship
Gender Eligibility: All
Minimum Age: 12 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Michel PAQUES, Principal Investigator, Centre Hospitalier National d’Ophtalmologie des Quinze-Vints
- Overall Contact(s)
- Tania RILCY, +33 140021126, trilcy@15-20.fr
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.